# The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF).

Study · id `cardio:ct-nct02671903` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02671903](<https://clinicaltrials.gov/study/NCT02671903>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02671903

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.

## Technical summary

Registry record NCT02671903. Randomized; double masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2020-10-31 (actual). Results posted on 2025-02-04.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 198 participants (enrolled count; ClinicalTrials.gov record NCT02671903, source copy `cardio:ctgov-nct02671903-2025-02-04`, retrieved 2026-10-26)
- Started: 2016-01 (actual) (ClinicalTrials.gov record NCT02671903, source copy `cardio:ctgov-nct02671903-2025-02-04`, retrieved 2026-10-26)
- Primary completion: 2020-10-31 (actual) (ClinicalTrials.gov record NCT02671903, source copy `cardio:ctgov-nct02671903-2025-02-04`, retrieved 2026-10-26)
- Completion: 2020-10-31 (actual) (ClinicalTrials.gov record NCT02671903, source copy `cardio:ctgov-nct02671903-2025-02-04`, retrieved 2026-10-26)
- Results first posted: 2025-02-04 (ClinicalTrials.gov record NCT02671903, source copy `cardio:ctgov-nct02671903-2025-02-04`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02671903, source copy `cardio:ctgov-nct02671903-2025-02-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02671903-2025-02-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF).
- Acronym: HOPE-HF
- Condition: Heart Failure
- Intervention (Device): Pacemaker: AV optimised, His pacing.
- Lead sponsor: Imperial College London
- Lead sponsor class: OTHER
- Collaborator: British Heart Foundation
- Collaborator class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Imperial College London (`cardio:org-imperial-college-london`)
- Registry lists this organization as a collaborator: British Heart Foundation (`cardio:org-british-heart-foundation`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: c5f259d9d5907136e68cd92d7e8cf4d3316fecce239ee8a6c035da5ed8938c11
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
